ClearPoint Neuro
CLPT
21 hedge funds and large institutions have $4.2M invested in ClearPoint Neuro in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
24% more capital invested
Capital invested by funds: $3.4M → $4.2M (+$808K)
24% more funds holding
Funds holding: 17 → 21 (+4)
0.97% more ownership
Funds ownership: 4.79% → 5.76% (+0.97%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$363K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$359K |
| 3 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
+$114K |
| 4 |
RFC
Regions Financial Corp
Birmingham,
Alabama
|
+$48.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$47.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$181K |
| 2 |
Goldman Sachs
New York
|
-$168K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$52K |
| 4 |
Morgan Stanley
New York
|
-$4.36K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$1.24K |
CLPT Hedge Fund Activity: Q4 2019 in Review
21 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2019, worth a combined $4.2M — up 24% from $3.4M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CLPT positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $363K. The largest seller was Millennium Management, cutting an estimated $181K.
- 21 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2019, up from 17 in Q3 2019.
- Funds reported $4.2M of ClearPoint Neuro stock for Q4 2019, up 24% quarter-over-quarter.
- 6 funds opened new ClearPoint Neuro positions in Q4 2019 and 2 closed out, a net change of +4 holders.
- The largest ClearPoint Neuro buyer in Q4 2019 was Vanguard Group, an estimated $363K added.
- The largest ClearPoint Neuro seller in Q4 2019 was Millennium Management, an estimated $181K sold.
Based on aggregated 13F filings for Q4 2019.